Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
Top Cited Papers
- 30 September 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 14 (10), 943-952
- https://doi.org/10.1016/s1470-2045(13)70341-3
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)Journal of Clinical Oncology, 2013
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trialThe Lancet, 2012
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is PlannedThe New England Journal of Medicine, 2011
- Hodgkin's Lymphoma — The Great TeacherThe New England Journal of Medicine, 2011
- Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorialBMC Medical Research Methodology, 2010
- Checking consistency in mixed treatment comparison meta‐analysisStatistics in Medicine, 2010
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's DiseaseThe New England Journal of Medicine, 2003
- Calculating the number needed to treat for trials where the outcome is time to an eventBMJ, 1999